Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

336 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Jingushi K, Kawashima A, Saito T, Kanazawa T, Motooka D, Kimura T, Mita M, Yamamoto A, Uemura T, Yamamichi G, Okada K, Tomiyama E, Koh Y, Matsushita M, Kato T, Hatano K, Uemura M, Tsujikawa K, Wada H, Nonomura N. Jingushi K, et al. Among authors: tsujikawa k. Cancer Immunol Immunother. 2022 Dec;71(12):2999-3011. doi: 10.1007/s00262-022-03213-5. Epub 2022 May 22. Cancer Immunol Immunother. 2022. PMID: 35598195 Free PMC article.
LOXL2 status correlates with tumor stage and regulates integrin levels to promote tumor progression in ccRCC.
Hase H, Jingushi K, Ueda Y, Kitae K, Egawa H, Ohshio I, Kawakami R, Kashiwagi Y, Tsukada Y, Kobayashi T, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K. Hase H, et al. Among authors: tsujikawa k. Mol Cancer Res. 2014 Dec;12(12):1807-17. doi: 10.1158/1541-7786.MCR-14-0233. Epub 2014 Aug 4. Mol Cancer Res. 2014. PMID: 25092917 Free article.
miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
Jingushi K, Ueda Y, Kitae K, Hase H, Egawa H, Ohshio I, Kawakami R, Kashiwagi Y, Tsukada Y, Kobayashi T, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K. Jingushi K, et al. Among authors: tsujikawa k. Mol Cancer Res. 2015 Mar;13(3):565-74. doi: 10.1158/1541-7786.MCR-14-0300. Epub 2014 Nov 7. Mol Cancer Res. 2015. PMID: 25381221 Free article.
MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma.
Matsuzaki K, Fujita K, Jingushi K, Kawashima A, Ujike T, Nagahara A, Ueda Y, Tanigawa G, Yoshioka I, Ueda K, Hanayama R, Uemura M, Miyagawa Y, Tsujikawa K, Nonomura N. Matsuzaki K, et al. Among authors: tsujikawa k. Oncotarget. 2017 Apr 11;8(15):24668-24678. doi: 10.18632/oncotarget.14969. Oncotarget. 2017. PMID: 28160564 Free PMC article.
336 results